New. Cornell univ.Med.~oll.,Dept.Ped., New ~o r k City Knowledge of fetal drug metabolism is a necessary prerequisite for determining the safe and rational use of drug therapy during pregnancy. Heme synthesis and drug metabolism were studied in 40 human fetuses aborted by hysterotomy and prostaglandins.Aaminolevulinic acid synthetase (ALAS),the rate limiting enzyme in heme synthesis,could be measured in livers and adrenals of fetuses aborted by hysterotomy but not in fetuses aborted by prostaglandins. Mean levels of ALAS f SE were 74.3 f 6.4 n(lmol/gm liver in 5 fetuses aborted by hysterotomy. Aryl hydrocarbon hydroxylase activity (AHH) was highest in the adrenal gland and progressively lower in liver, intestine, testes, kidney and lung in fetuses from both groups, AHH activity in the adrenal gland was positively correlated with the concentration of microsomal cytochrome P-448 and negatively correlated with the concentration of cytochrome P-420. Secobarbital when added to human fetal liver and adrenal microsomes resulted in a type I1 difference spectrum (peak 430 nm, trough 406 nm) although when added to microsomes from chick embryos a type I spectrum (peak 385 nm, trough 419 nm) resulted. These studies 1) supply the first reported measurements of AIAS in human fetal tissues, 2) show that fetuses aborted by prostaglandins are useful for studies of AHH activity, 3) provide evidence that AHH in the fetal adrenal is mediated by cytochrome P-448 and 4 ) show species differences in substrate binding to embryonic microsomal proteins.
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Gunn r a t ericephalooathy i s a t t r i b u t e d t o t h e t o x i c a c t i o n o f b i l i r u b i n b u t t h e b r a i n b i l i r u b i n c o n t e n t o f young r a t s h a s n o t beeii ? r e v i o u s l y :
,leasured. Homozygous i n f a n t r a t s a r e u s u a l l y h e a l t h y and t h e i r b r a i n s do n o t shov! any v i s i b l e yello,:. d i s c o l o r a t i o n a l t h o u g h e x t c n s i v e neurons1 de&enera-t i o n i s c o n s t a n t l y present (Ijose i Johrlson, 1472) . b i l i r u b i n c o n t e n t s h a s been d e t e r : i~i n c l by l i g h t a b s o r p t i o n a t Lt5Jnr:-o f chloi-o;orr. These d a t a shoa t h a t ( a j i n Gunn -a t 3 tile 1 0 s~ 3 f neurons o c c u r s even :./hen o n l y t r a c c a~o u i~t s of b i l i r u b i n a r c !jrese:lt i n tile Cis&; ( b ) t h e i n c r e a s s d e n t r y o f b i l i r u b i n i n t o t h e b r a i n follo'?iing i n ject i o n o f s u l f a d i n e t h~x i n e i s f u r t h e r ag-lrentcd by asphyxia. (Supported by ,;I;i Grant 1 : : b~~i i~ 0,;364i *lOOs;gz/:;g i.9. i n j e c t i o n . The relationships between maternal dose of methadone and neonatal withdrawal, and between neonatal plasma levels of methadone ([MI) and symptomatoloqy have been investiqated. Piethadone was analvzed bv gas chromatography; recovery was 88-94 % in the 0.1-1.0 u g h 1 ranqe. Ten mothers and their neonates were studied: 3 mothers were taking methadone 10 mg/dav and 5, 40-60 mg/day; 2 mothers were detoxified durinq the 3rd trimester of preanancy. All 8 infants of mothers on methadone exhibited withdrawal; 3 had no detectable[plJin the 1st 24 hours of life; 2 of these beqan withdrawal in the 1st few hours of life and the 3rd after 24 hours. In the other 5 svmptomatic infants at birth = 0.07-.14 uq/ml; in 4 , W = 0-.06 ua/ml after 24 hours, at which time withdrawal beqan, and the 5th hadl~]=0.12 ua/ml at 24 hours with no detectablewat 48 hours. Withdrawal commenced in this infant shortlv thereafter. Neither infant of the detoxified mothers developed withdrawal nor had thev anv detectabler~] at birth. Thus there appears to be no relationship between maternal dosages of methadone (10-60 ma/dav) and the time of onset of neonatal withdrawal. Infants born to mothers who are druq-free in the 3rd trimester do not withdraw. Newborns withiMJ=.07--14 ua/ml do not withdraw: withdrawal begins whenl~l falls to 0--06 ug/ml.
DrMINISHED RESPONSE OF HEPATIC GLUCURONYL-TRANSFERASE TO PHE-
Bilirubin (B) glucuronyl-transferase (GT) activity was studied in liver homogenates of pregnant (P) and non-pregnant (NP) female rats. Activity in NP rats was 1286+166(S.D.) ug B conjugatedlg liver140 min (N=13) and in P rats (5 to 21 days gestation) was 1271+211 (N=43). No change in maternal liver GT activity was observed during pregnancy. Administration of phenobarbital (PB)(lOOmg/Kg) to 6 NP rats for 3 days increased GT activity to 2061'208 (62%). We have described previously an increased sensitivity of immature rodents to HCP, a finding which may relate to the reported high incidence of suggestive neuropathological changes found in exposed low-birth-weight infants. This age-dependent sensitivity in rodents can be accounted for by slower elimination of HCP. In adult rats and mice, biliary excretion accounts almost quantitatively for elimination of 14~-HCP, with 98% of label in bile present as the monoglucuronide (HCP-G). HCP-G is identified by chemical and enzymatic hydrolyses, and mass spectral analysis. Elimination of HCP from plasma is 6-fold slawer in 3-day-old animals, yet bile and small intestinal contents exhibit comparable concentrations of radioactivity. Surprisingly, in the neonate 90% of label in bile is HCP, not HCP-G. The radiolabel in livers from young and adult rodents is primarily HCP. Adult-type elimination and biliary compositions are approached by 2 weeks of age. These results are compatible with an important contribution of enterohepatic circulation to the overall pharmacokinetic profile of HCP in immature rodents. Bile salt synthesis and pool size were determined by stable isotope dilution in 9 healthy premature infants of 32-36 wk gestation. In one qroup (4 infants), the mothers had received dexamethasone (3) or phenobarbital (1) prior to delivery; the other mothefihad received no drugs. For infants of the treated mothers, total bile salt pool was 79 2 20 mg (avg + SE) and synthesis was 27 + 5 mg/da; whereas in infants of untreated mothers, total bile salt pool was 20 2 2 mg and synthesis was 8 + 1 mg/da. When normalized for surface area, the cholic acid pool in the treated qroup was 321 + 117 m g /~~ and synthesis was 98 + 35 rng/~~/da, values equal to those obtained in full-term infants and 4 times those in the qroup with untreated mothers. Intraduodenal bile salt concentrations during meals in the treated group were 5.3 mM vs 1.2 mM for the untreated qroup, an increase associated with improved dietary lipid absorption to>30% of intake in 3 of 4 infants. Conclusions: (1) Premature infants have immature bile salt metabelism as demonstrated by reduced pool size and synthesis rates with intraduodenal bile salt concentrations below levels required for the complete solubilization of lipid. (2) Prenatal administration of dexamethasone or phenobarbital produces precocious maturation of these parameters and thus may profoundly influence the postnatal nutrition of the premature infant.
